What is glp-1+GIP?

Thirzepatide is an innovative discovery in the treatment of type 2 diabetes and obesity. Acting on a single peptide, this advanced formulation is revolutionizing the approach to these conditions. What sets it apart? Tirzepatide Activates two important gut hormones - GLP-1+GIP - Which naturally regulate blood glucose levels and control appetite.

Thanks to the unique synthetic substances contained in thiropatide, sensational results have been achieved. After eating a meal, you quickly feel satiety, and blood sugar levels do not rise sharply. This makes both diabetes control and weight reduction much easier, so it is readily used during weight loss. 

Studies have shown that thiothiazepatide is superior to current treatments in terms of efficacy, no doubt in terms of ease of use. In addition, it can be particularly helpful for people suffering from obesity and overweight. With regular administration once a week, thirzepatide affects the receptors of the GLP-1+GIP, which leads to a decrease in appetite, an increase in energy expenditure, then to a gradual reduction in body weight.

The secret of thiothiodate lies in its ability to mimic the natural hormones released by the intestines after a meal. It works by delaying the emptying of the stomach and stimulating the sensation of satiety in the hypothalamus, which effectively inhibits the feeling of hunger, consequently, you eat less. 

Thirzepatide opens a new era in the treatment of diabetes and obesity, offering patients a more effective and comfortable solution. It can improve diabetes control, reduce appetite and achieve a healthy body weight.

How does GLP-1+GIP work?

Thirzepatide is a substance that mimics the effects of incretins - are hormones that our body naturally produces after eating a meal. This peptide works by binding to specific receptors in our body. These are the same receptors that become targets for two key hormones - glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). These two hormones are normally produced in our gut.

It is non-trivial that Tirzepatide works on a similar principle as GLP-1+GIP. This ensures that the pancreas is properly stimulated to secrete insulin, but only when it is actually needed. That is, situations when we are dealing with too high a concentration of sugar in the blood. The key thing is that thanks to this property, Thirzepatide does not cause hypoglycemia.

But the benefits don't end there! Thirzepatide increases the feeling of satiety and helps inhibit cravings, and this is important not only for those struggling with sugar problems, but also for those with normal blood sugar levels. Consequently, it can be used to get rid of excess body weight. 

In one clinical study, Thirzepatide showed its strong effects in reducing liver fat. Interestingly, these effects were observed even at the lowest dose. In some patient cases, after a year's follow-up, their liver fat content was found to have dropped from 27% to just 3%. In summary, the product not only slims down, but also improves the condition of your organs. 

Effects after GLP-1+GIp

Research have confirmed that a weekly dose of a new formula that has gained approval from the U.S. Food and Drug Administration makes it much easier to fight obesity or overweight. This undoubted discovery shows that Healthy individuals can lose up to 25 percent of their initial weight with peptide treatment. The results are so impressive that they can be compared to those of bariatric surgery. Equally important in this is the fact that the treatment did not require significant changes in the lifestyle of the subjects. Of course, the better our diet and workouts are, the stronger the effects are sure to be. 

One study, which was conducted on a group of 2,500 non-diabetics with type 1 diabetes, observed astonishing results. More than 60 percent of patients struggling with obesity or overweight who took a dose between 5-15 mg of the drug for more than a year managed to reduce at least 20 percent of their. total body weight. What's more, some of them have managed to lose from 22.5 to 25 percent of its weight, which translated into up to 28 kg less on the scale. This is certainly a result that will interest any person who cares about his health and figure. 

Benefits of using the peptide

  • lowers body weight
  • reduces appetite
  • prolongs the feeling of satiety (resulting from delayed gastric emptying by the peptide)
  • Regulates (not lowers) blood glucose levels
  • slows down the digestion of food in the stomach protect the heart and kidneys from diabetic complications. 
  • lowers blood pressure and blood lipid levels
  • lowers glycated hemoglobin concentrations

What is glp-1+GIP?

Thirzepatide is an innovative discovery in the treatment of type 2 diabetes and obesity. Acting on a single peptide, this advanced formulation is revolutionizing the approach to these conditions. What sets it apart? Tirzepatide Activates two important gut hormones - GLP-1+GIP - Which naturally regulate blood glucose levels and control appetite.

Thanks to the unique synthetic substances contained in thiropatide, sensational results have been achieved. After eating a meal, you quickly feel satiety, and blood sugar levels do not rise sharply. This makes both diabetes control and weight reduction much easier, so it is readily used during weight loss. 

Studies have shown that thiothiazepatide is superior to current treatments in terms of efficacy, no doubt in terms of ease of use. In addition, it can be particularly helpful for people suffering from obesity and overweight. With regular administration once a week, thirzepatide affects the receptors of the GLP-1+GIP, which leads to a decrease in appetite, an increase in energy expenditure, then to a gradual reduction in body weight.

The secret of thiothiodate lies in its ability to mimic the natural hormones released by the intestines after a meal. It works by delaying the emptying of the stomach and stimulating the sensation of satiety in the hypothalamus, which effectively inhibits the feeling of hunger, consequently, you eat less. 

Thirzepatide opens a new era in the treatment of diabetes and obesity, offering patients a more effective and comfortable solution. It can improve diabetes control, reduce appetite and achieve a healthy body weight.

All descriptions are based on  scientific sources. They are for informational purposes only.

Comparison of studies of two receptors on the chart

GLP-1 +gip
kg
GLP-1
kg